SCHEMBL6850104

SCHEMBL6850104

O=C(N[C@@H]1CN2CCC1C2)c1cc2c(Cl)coc2cn1

nearest known ligand 0.58

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 9/20 0.58
HTR3A P46098 9/20 0.58
HTR3E A5X5Y0 5/20 0.58
HTR3B O95264 5/20 0.58
HTR3D Q70Z44 5/20 0.58
HTR3C Q8WXA8 5/20 0.58
KCNH2 Q12809 1/20 0.43
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
CYP2D6 P10635 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5917964 1.00 CHRNA7 (0.58) CHRNA7HTR3AHTR3EHTR3BHTR3D
SCHEMBL843326 1.00 CHRNA7 (0.58) CHRNA7HTR3AHTR3EHTR3BHTR3D
SCHEMBL6009278 0.95 HTR3A (0.64) CHRNA7HTR3AHTR3EHTR3BHTR3D
SCHEMBL5917918 0.95 HTR3A (0.64) CHRNA7HTR3AHTR3EHTR3BHTR3D
Fumaric Acid SCHEMBL842698 0.94 CHRNA7 (0.52) CHRNA7HTR3AHTR3EHTR3BHTR3D
Hydrochloric Acid SCHEMBL6008560 0.94 HTR3A (0.63) CHRNA7HTR3AHTR3EHTR3BHTR3D
SCHEMBL843393 0.90 CHRNA7 (0.58) CHRNA7HTR3AHTR3EHTR3BHTR3D
SCHEMBL843491 0.88 CHRNA7 (0.58) CHRNA7HTR3AHTR3EHTR3BHTR3D
SCHEMBL879090 0.88 CHRNA7 (0.58) CHRNA7HTR3AHTR3EHTR3BHTR3D
SCHEMBL5917933 0.88 CHRNA7 (0.58) CHRNA7HTR3AHTR3EHTR3BHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432707-A1 AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-06-30 EP claimed
WO-2003029252-A1 AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2003-04-10 WO claimed